A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Clinical trial NCT03773965 · RECRUITING
Trial details
- NCT number
- NCT03773965
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-05
- Primary completion
- 2031-07-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.